I worked for a company specialized in the Crop Control industry with an innovative Microbials product portfolio. This is a regulated sector, with tough competition from traditional chemical companies, particularly big multinationals. The Global Biocontrol Market exceeds the $2.5bn per year, at a grower level. So the addressable market size for them is massive.
Determining the right strategy to commercialize their innovation and to grow is key for the future of the company.
Working for 2 SMEs who have developed disruptive methodologies to improve medical treatments in human beings:
- One of them, making more efficient the drug discovery process through DNA recombinant technology, RNAi & protein interactions
- The other one, contributing to cures for illnesses of genetic origin through the development of a new generation of viral vectors